Table 1

Basic data and treatment outcome for group A and group B

Group A – sclerosing injectionsGroup B – arthroscopy
VariableMean (SD)Mean (SD)Significance (p value)
Age, years27.0 (7.6)26.6 (7.6)0.755
Duration of symptoms, months20.0 (10.4)23.8 (15.5)0.596
VAS at rest at assessment37.8 (24.9)44.6 (28.4)0.431
VAS at activity at assessment69.0 (17.3)76.5 (13.6)0.143
Follow-up time, months13.7 (6.9)12.9 (7.8)0.719
VAS at rest at follow-up19.2 (23.2)5.0 (8.3)0.004
VAS at activity at follow-up41.1 (28.5)12.8 (19.3)0.001
Satisfaction with result, 0–10052.9 (32.6)86.8 (20.8)0.000
  • VAS, visual analogue scale.